Altered type III collagen turnover measured in pre-treatment serum predicts outcome in metastatic melanoma patients treated with Ipilimumab. (March 2018) - Jensen, C.; Madsen, D.; Hansen, M.; Schmidt, H.; Svane, I.; Karsdal, M.; Willumsen, N.